Latest Conference Articles

Oncology Nursing Expert Previews 37th Annual ONS Congress

With four full days of programming, dozens of exhibitors, satellite symposia, and thousands of members in attendance, trying to fit everything in at the ONS Annual Congress can prove quite challenging.

Oncology Nursing Society Elects New President

This year's ONS Annual Congress marks the first at which Mary Gullatte, PhD, RN, APRN, BC, AOCN, will serve as the organization's president.

Conference Coverage From the ATA Annual Meeting

Conferencd coverage from the 82nd Annual Meeting of the American Thyroid Association (ATA).

Conference Coverage From AACE Coming Soon

Stay tuned for live coverage from the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress.

Preview: 2012 ASCO Annual Meeting Coverage

OncLive.com will be on-site at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

Dr. Tripathy Discusses Breast Cancer Prevention

Dr. Debu Tripathy, from the USC Norris Comprehensive Cancer Center, Discusses Breast Cancer Prevention

Emerging Therapies for HER2-Positive and Triple-Negative Breast Cancers

Recognition of breast cancer subtypes and research into their underlying biologies is driving the development of new therapies.

Dr. Gralow on Breast Cancer Adjuvant Bisphosphonates

Dr. Julie Gralow, from the Seattle Cancer Care Alliance, on Adjuvant Bisphosphonates for Breast Cancer

Immunotherapy Emerges as Promising Strategy in Breast Cancer

Next-generation immunotherapy in breast cancer treatment is an active field of scientific exploration with the potential to yield a vaccine.

Dr. Osman on the 29th Miami Breast Cancer Conference

Dr. Daniel Osman, the program chair for the Miami Breast Cancer Conference, Discusses the 29th Annual Meeting

Advances in Genomics Mask Complexities

Technological advances in genomics have prompted a "sea change" in breast cancer drug development and treatment.

Patients, Surgeons Face Hurdles in Making Breast Cancer Decisions

The choice of breast-conserving surgery over mastectomy is often based on fear of recurrence and death rather than clinical evidence.

29th Annual Miami Breast Cancer Conference Slideshow

Pictures from the Annual Miami Breast Cancer Conference, at the Fontainebleau Miami Beach hotel, in Florida.

Four Key Areas Are Focus of ASCO/SABCS Highlights

Debu Tripathy, MD, culled the highlights from abstracts presented in 2011 at the ASCO annual meeting in Chicago, Illinois, and at the CCTR-AARC SABCS in Texas.

29th Annual Miami Breast Cancer Conference Opens

The impact of molecular and genomic advancements on the treatment of patients with breast cancer will be among the prime topics of discussion.

Miami Breast Cancer Conference Founder Keeps Focus on Future

As the Miami Breast Cancer Conference enters its 29th year, Osman continues to organize the gathering and pack the 4-day meeting with faculty speakers.

Dr. Steensma Discusses Iron Chelation Therapy for MDS

Dr. David Steensma, from Dana-Farber Cancer Institute, Discusses Iron Chelation Therapy for MDS

Managing Chronic Myeloid Leukemia Treatment

Certain characteristics of patients with CML can affect therapeutic outcomes.

New Model Helps Guide Treatment Options in CLL

A number of prognostic factors can help identify those at a high risk for CLL progression who may benefit from early intervention.

Dr. Erba Describes Proper Diagnostic Testing of CML

Dr. Harry Erba, from the University of Michigan Health System, Describes Proper Diagnostic Testing of CML

2012 ONS Congress Coverage Coming Soon

Meeting coverage from the 2012 Oncology Nursing Society Congress held at the New Orleans Ernest N. Morial Convention Center, from May 3-6, 2012.

Dr. Dunleavy Discusses 3 Molecular Subtypes of DLBCL

Dr. Kieron Dunleavy from the National Cancer Institute Discusses 3 Molecular Subtypes of DLBCL

Current Trends in the Treatment of Newly Diagnosed Myeloma

A number of studies suggest that there is a right and wrong way to proceed with initial therapy and transplant eligibility for patients with multiple myeloma.

New Directions in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Research has shown that DLBCL is heterogeneous, suggesting that patients with varying subtypes should receive different courses of treatment.

Dr. Ansell on Waldenstrom Macroglobulinemia Types

Dr. Stephen Ansell from the Mayo Clinic Describes Waldenström Macroglobulinemia

Noted Researcher Sees ERT as Remarkable Beginning

The treatment of Gaucher disease is poised to enter a new era as a result of advances in the understanding of the cellular pathways at work in the disorder.

Same Mission, New Role for Genzyme Executive: Head of Rare Diseases Committed to Patients

Rogerio Vivaldi, MD, has vivid memories of the first patient with Gaucher disease ever treated in Brazil with enzyme replacement therapy.

Lysosomal Storage Disorders: Marking Milestones and Moving Forward

The mood of the ICHG/ASHG 2011 congress often seemed buoyant as researchers discussed the doors that technology is helping to open.

Dr. Grabowski Explains the Effects of Enzyme Therapy

Dr. Gregory Grabowski, from the University Cincinnati, Explains the Effects of Enzyme Therapy

Dr. Mistry Discusses His Experience With Gaucher Disease

Pramod K. Mistry, MD, PhD, from Yale University, discusses Gaucher disease